Rocket Fuel


Print    Email
Decrease (-) Restore Default Increase (+)

Renal Cell Cancer Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type



Patients must have histologically or cytologically confirmed RCC (clear cell or non-clear cell allowed, collecting duct or medullary carcinoma excluded).

EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study. Learn more

©  2014 

Holy Cross Hospital | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000